The interaction effect of grapefruit juice is maximal after the first glass

European Journal of Clinical Pharmacology

Volumn 54, Issue 1, 1998, Pages 75-81

  Lundahl, J U E ^a   Regardh C G ^b   Edgar, B ^b   Johnsson, G ^b  

^a Box 300 47 ^*  (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; FELODIPINE;

ADULT; ANTIHYPERTENSIVE THERAPY; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE REGULATION; CITRUS FRUIT; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG ACCUMULATION; DRUG EFFECT; DRUG METABOLISM; FOOD DRUG INTERACTION; FOOD INTAKE; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ADULT; BEVERAGES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CITRUS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FELODIPINE; HEART RATE; HUMANS; MALE;

EID: 0031958901     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050424     Document Type: Article

References (23)

1. Balley D, Spence D, Edgar B, Bayliff C. Arnold M (1989) Elhanol enhances the haemodynamic effects of felodipine. Clin invest Med 12: 357-362
2. Lundahl J, Ragårdh CG. Edgar B and Johnsson G (1995) Relationship between time of intake of grapefruit juice and its effects on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur J Clin Pharmacol 49: 61-67
3. Josefsson M, Zackrisson A-L, Ahlner J (1996) Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers. Eur J Clin Pharmacol 51: 189-193
4. Ducharme M, Warbasse L, Edwards D (1995) Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharm Ther 57 [Suppl 5]: 485-491
5. Ducharme MR, Provenzano R, Dehoome-Smith M, Edwards DJ (1993) Trough concentrations of cyclosporine following administration with grapefruit juice. Br J Clin Pharmacol 36: 457-459
6. Proppe D, Hoch O, Visser K, Maclean AJ (1995) Implication for clinical dosage management of steady-state cyclosporin a and metabolite pharmacokinetics in renal patients. Abstract of the ASCPT meeting, Sen Diego, PII-112, 191
7. Yee GC, Stanley DL, Pessa LJ, Costa TD, Beltz SE, Ruiz J, Lowenthal DT (1995) Effects of grapefruit juice on blood cycloporine concentration. Lancet 345: 955-956
8. Benton R, Honig P, Zamani K, Hewett J, Cantilena LR. Woosley RL (1994) Grapefruit juice alters terfenadine pharmacokinetics resulting in prolongation of QTc (abstract). Clin Pharmacol Ther 55: 146
9. Honig P, Wortham D, Lazarev A, Cantilena LR (1995) Pharmacokinetics and cardiac effects of lerfenadine in poor metabolizers receiving terfenadine concimitant grapefruit juice. Abstract of the ASCPT meeting, San Diego. PII-87. 185
10. Balogh A, Webor A, Klinger G (1994) Can grapefruit juice influence the bioavailability of ethinylestradiol? Abstract of the 4th Annual Meeting of the German Society of Clinical Pharmacology and Therapy, Hannover, 93
11. Schubert W, Culberg G, Edgar B, Hedner T (1994) Inhibition of 17beta-estradiol by grapefruit juice in ovariectomized women. MATURITAS 20: 155-163
12. Kupferschmidt H, Ha H, Ziegler W, Meier P, Krähenbühl S (1995) Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 58: 20-28
13. Fuhr U, Kittich K, Staib H (1993) Inhibitory effect of grapefruit juice and its bitter principal. naringenin. on CYPT1A2 dependent metabolism of caffeine in man. Br J Clin Pharmac 35, 431-436
14. Merkel U, Sigusch H and Hoffmann A (1994) Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers. Eur J Clin Pharmacol 46: 175-177
15. Lundahl J, Regårdh CG, Edgar B, Johnsson G (1997) Effects of concomitant grapefruit juice ingestion pharmacokinetics and haemodynamics of intravenously and orally administrated felodipine in healthy men Eur J Clin Pharmacol 52: 139-145
16. Rashid TJ, Martin U, Clarke H, Waller DG, Renwick AG, George CF (1995) Factors affecting the absolute bioavailability of nifedipine. Br J Clin Pharmacol 40: 51-58
17. Ahnoff M (1984) Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. J Pharm Biomed Analysis 2: 519-526
18. Edgar B, Bailey DG, Bergstrand R, Johnsson G, Regardh CG (1992) Acute effect of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine and its potential clinical relevance. Eur J Clin Pharmacol 42: 313-317
19. Lown et al (1997) Grapefruit juice increases felodipine oral bioavailability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 99: 2545-2553
20. Blychert E, Hedner T, Dehlöf C, Elmfeldt D (1990) Plasma concentration-effect relationships of intravenous and extended-release oral felodipine in hypertensive patients. J Cardiovasc Pharmacol 15: 428-435
21. Weisser B, Lieder P, Göbel B, Vetter H, Düsing R (1990) Baroreceptor activity in man during administration of the calcium channel blocker felodipine. Int J Clin Pharmacol Res 10: 325-330
22. Bengtsson-Hasselgren B, Röhn O, Blychert LO, Edgar B (1990) Acute effects of felodipine on hepatic and foream blood flow in healthy men. Eur J Clin Pharmacol 38: 529
23. Elvelin L, Jönsson L (1994) The effect of dihydropyridine calcium antagonists on heart rate: studies of felodipine. Current Ther Res 55 [Suppl 7]: 736